Description:

This study seeks participants to help us evaluate the effectiveness of promising new medication focused on preventing migraines. Because this medication focuses on reducing the number of migraines per month, participants must have had at least 8 migraines each month, with at least 1 headache-free day. This study will last at least 30 weeks and consist of 9 study appointments during that time. 

Qualified Participants are: 

• Experiencing chronic migraines (at least 8 a month) 

Location:

10575 Springfield Ave, Suite A

Cincinnati, Ohio 45215

(513) 978-5070